October 8, 2012 — Simbionix USA Corp. will introduce the new advanced U/S (ultrasound) Mentor simulator at the upcoming American College of Emergency Physicians (ACEP) Exhibition in Denver, Colo. This new Simbionix simulator offers realistic hands-on training for diverse ultrasound examinations and interventions.

Following Health Canada approval, Cook Medical has made the Zilver Vena Venous Self-Expanding Stent available to physicians across Canada. Designed to restore blood flow in obstructed iliofemoral veins, Zilver Vena provides physicians with a tool designed specifically for stenting obstructed iliofemoral veins.

October 8, 2012 — St. Jude Medical Inc. has launched MediGuide Technology, the first 3-D navigation system intended for the evaluation of vascular and cardiac anatomy on a recorded fluoroscopic image instead of live fluoroscopy. The use of recorded images allows physicians to reduce the duration of radiation exposure during cardiovascular procedures, especially during long procedures in the electrophysiology (EP) lab.

The U.S. Food and Drug Administration (FDA) has granted Clinical Laboratory Improvement Amendments (CLIA)-waived status to the Roche CoaguChek XS Plus system. The point-of-care anticoagulation monitor offers connectivity and data management tools to help healthcare professionals manage PT/INR (blood clotting time) testing. The waiver means that the monitoring technology may now be used in a broader range of clinical settings, such as labs that do not meet the requirements to perform moderate- or high-complexity testing as defined by the CLIA of 1988.

Imagine a place where doctors can tell patients in advance if cancer treatment will work for them, without going through an entire course of chemotherapy.

Advocate Health Care, one of the nation's top health systems and the largest integrated health care system in the state of Illinois, and GE Healthcare, a national leader in low dose, high performance imaging, announced a joint effort to help further reduce radiation dose in computed tomography (CT). The goal is to optimize care for patients needing imaging procedures and reduce radiation where possible without adversely impacting image quality. It’s one of the first announcements of the GE Blueprint for low dose, a comprehensive campaign in which GE Healthcare is working alongside leading U.S. health systems to further reduce radiation dose in CT imaging. Leaders from Advocate and GE Healthcare unveiled the Advocate-based GE Blueprint for low dose today during an event at Advocate Lutheran General Hospital.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now